Kv3 modulator 1

CAS No. 1380696-64-9

Kv3 modulator 1( —— )

Catalog No. M32988 CAS No. 1380696-64-9

Kv3 modulator 1 is a voltage-gated potassium channel Kv3 modulator that can be used to study neurologic-level diseases.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 567 Get Quote
5MG 848 Get Quote
10MG 1159 Get Quote
25MG 1674 Get Quote
50MG 2190 Get Quote
100MG 2790 Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Kv3 modulator 1
  • Note
    Research use only, not for human use.
  • Brief Description
    Kv3 modulator 1 is a voltage-gated potassium channel Kv3 modulator that can be used to study neurologic-level diseases.
  • Description
    Kv3 modulator 1 is a Kv3 voltage-gated potassium channel modulator extracted from patent WO2018020263A1, Compound X. Kv3 modulator 1 has the potential for inflammatory pain treatment.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Cell Cycle/DNA Damage
  • Target
    Potassium Channel
  • Recptor
    Potassium Channel
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1380696-64-9
  • Formula Weight
    380.4
  • Molecular Formula
    C20H20N4O4
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    O=C1NC(C(=O)N1C2=CN=C(N=C2)OC3=CC=C(C=4OCC5(C34)CC5)C)(C)C
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Giuseppe Alvaro, et al. Cyclobutane derivatives as modulators of voltage-gated potassium channels. WO2018020263A1.
molnova catalog
related products
  • PF-04895162

    PF-04895162 (ICA-105665, PF 4895162) is an orally available agonist of neuronal Kv7 potassium channel, opens Kv7.2/7.3 and Kv7.3/7.5 potassium channels.

  • Doxapram

    Doxapram (Dopram) is a respiratory stimulant that inhibits TASK-1, TASK-3, and TASK-1/TASK-3 heterodimer channels and is used to study ventilatory failure caused by apnea of ??prematurity and exacerbation of chronic obstructive pulmonary disease.

  • BeKm 1

    Potent and selective KV11.1 (hERG) channel blocker. Selective for KV11.1 over a panel of 14 other potassium channels. Dose-dependently prolongs QTc interval in isolated rabbit heart.